0 0 0.000220716159019448 0.00167484614785381 0.00476487237412682 0.00780945703824879 0.00978941081768841 0.00802368154553238
Sign Up Today X
Thanks for submitting the form.
Stockreport

Regeneron: Fairly Valued Now After A Stellar Upswing [Seeking Alpha]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Seeking Alpha
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
Declining Eylea/Eylea HD revenues are largely offset by strong Dupixent growth, with Dupixent likely to exceed 50% of total revenue by 2027. Libtayo and pipeline assets show promise, but meaningful revenue impact is expected only after 2026; diversification into new areas brings both opportunity and capital allocation risk. REGN maintains a robust balance sheet and FCF, but falling ROIC and high SBC warrant monitoring as R&D spending accelerates. Solskin/DigitalVision via Getty Images Regeneron Pharmaceuticals, Inc. ( REGN ) is a well-established biotech company based in Tarrytown, NY, that has had a phenomenal journey since its founding in 1988, but most clearly – for shareholders – since it reached an inflection point in 2011 when the This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of VRTX, NVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

Regeneron: Fairly Valued Now After A Stellar Upswing [Seeking Alpha]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Seeking Alpha
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
Declining Eylea/Eylea HD revenues are largely offset by strong Dupixent growth, with Dupixent likely to exceed 50% of total revenue by 2027. Libtayo and pipeline assets show promise, but meaningful revenue impact is expected only after 2026; diversification into new areas brings both opportunity and capital allocation risk. REGN maintains a robust balance sheet and FCF, but falling ROIC and high SBC warrant monitoring as R&D spending accelerates. Solskin/DigitalVision via Getty Images Regeneron Pharmaceuticals, Inc. ( REGN ) is a well-established biotech company based in Tarrytown, NY, that has had a phenomenal journey since its founding in 1988, but most clearly – for shareholders – since it reached an inflection point in 2011 when the This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of VRTX, NVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS